Radio and PodcastLive Radio & PodcastsScience & Medicine
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
Oncology Times Broadcast News: Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer For adjuvant treatment of stage II and stage III colorectal cancer the vascular endothelial grow...
About This Episode
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer is an episode from Oncology Times Broadcast News. Oncology Times Broadcast News: Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Ther...
Podcast
This episode belongs to Oncology Times Broadcast News.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 28, 2009, 00:09:05 long, audio available.
Related Episodes
Continue listening to more episodes from Oncology Times Broadcast News.
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Sep 28, 2009 - 00:07:19
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
Sep 28, 2009 - 00:06:03
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer
Sep 28, 2009 - 00:02:18